Janssen India launches diabetes treatment drug
Taken orally once a day, Invokana belongs to a new class of medications which work in a completely different way to other classes of type 2 diabetes medications.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news
More News: Biotechnology | Canagliflozin | Diabetes | Diabetes Type 2 | Endocrinology | Invokana | Pharmaceuticals